Transition Therapeutics

Just because a drug has managed to successfully meet earlier trial goals, it's no guarantee it will continue to do so. On Tuesday, Gilead, Elan and Transition Therapeutics halted trials of experimental drugs that had previously showed promising results. Elan Corp. (ELN) and Transition Therapeutics...